Prednisone Treatment for Vestibular Neuronitis

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

May 31, 2007

Conditions
Vestibular DiseasesVestibular Neuronitis
Interventions
DRUG

Prednisone

PO, 1 mg/kg body weight, 5 days Short tapering regimen: daily reductions in the dose, 12 days

DRUG

Prednisone

PO, Placebo, 17 days

Trial Locations (4)

31096

Department of Otolaryngology Head and Neck Surgery, Rambam Medical Center, Haifa

34362

Department of Otolaryngology Head and Neck Surgery, Carmel Medical Center, Haifa

35152

Otoneurolgy Unit, Lin Medical Center, Clalit Health Services, Haifa

38100

Unit of Otolaryngology Head and Neck Surgery, Hillel Yaffe Medical Center, Hadera

Sponsors
All Listed Sponsors
collaborator

Clalit Health Services, Haifa and West Galilee

OTHER

collaborator

Hillel Yaffe Medical Center

OTHER_GOV

collaborator

Rambam Health Care Campus

OTHER

collaborator

University Health Network, Toronto

OTHER

lead

Carmel Medical Center

OTHER